| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142878 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 06/16/2011 | US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142870 Bacillus anthracis antigens, vaccine compositions, and related methods |
| 06/16/2011 | US20110142869 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine |
| 06/16/2011 | US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142864 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142862 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 06/16/2011 | US20110142852 Multispecific antibodies |
| 06/16/2011 | US20110142851 IL6 Immunotherapeutics |
| 06/16/2011 | US20110142847 Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 |
| 06/16/2011 | US20110142845 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF |
| 06/16/2011 | US20110142843 Fetal polypeptides from human liver |
| 06/16/2011 | US20110142841 Compositions and methods for the treatment of systemic lupus erythematosis |
| 06/16/2011 | US20110142825 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |
| 06/16/2011 | US20110142811 Measles virus for the elimination of unwanted cell populations |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142767 RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | DE112009000705T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same |
| 06/16/2011 | DE102009058169A1 Protein oder Polypeptid zur Bindung an Tubulin und/oder Mikrotubulistrukturen Protein or polypeptide to bind to tubulin and / or Mikrotubulistrukturen |
| 06/16/2011 | DE102009056945A1 DNA-Aptamere, die den löslichen Interleukin-6-Rezeptor spezifisch binden DNA aptamers that bind specifically to the soluble interleukin-6 receptor |
| 06/16/2011 | DE102004037652B4 Verfahren zur Modulation der Genexpression durch Änderung des CpG Gehalts Process for the modulation of gene expression by changing the CpG content |
| 06/16/2011 | CA2836117A1 Oncolytic rhabdovirus |
| 06/16/2011 | CA2820315A1 Hyperprimers |
| 06/16/2011 | CA2783876A1 New conjugates and compositions for immunotherapy and antitumoral treatment |
| 06/16/2011 | CA2783763A1 Insulin analogues with chlorinated amino acids |
| 06/16/2011 | CA2783669A1 Compositions comprising zinc finger domains and uses therefor |
| 06/16/2011 | CA2783563A1 Anti-inflammatory antibodies and uses therefor |
| 06/16/2011 | CA2783533A1 Heterologous expression of urease in anaerobic, thermophilic hosts |
| 06/16/2011 | CA2783351A1 Tal effector-mediated dna modification |
| 06/16/2011 | CA2783242A1 Method for identification of protease activity inhibitors and assaying the presence of protease activity |
| 06/16/2011 | CA2783032A1 Rna preparations comprising purified modified rna for reprogramming cells |
| 06/16/2011 | CA2783010A1 Method and composition to increase radiation-induced tumor therapeutic effects |
| 06/16/2011 | CA2782970A1 Method and device for synthesizing proteins from dna molecules captured in microchambers |
| 06/16/2011 | CA2782938A1 Methods for diagnosing and assessing risk of developing glomerulosclerosis |
| 06/16/2011 | CA2782936A1 Mice that make heavy chain antibodies |
| 06/16/2011 | CA2782545A1 Methods for increasing the resistance of plants to fungi by silencing the fungal smt1-gene |
| 06/16/2011 | CA2782298A1 Stomata-increasing agent, polypeptide, method for increasing number and/or density of stomata in plant, and method for increasing yield of plant |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333547A1 Process for producing microbeads and microbeads |
| 06/15/2011 | EP2333118A1 Method for rapid detection and identification of bioagents |
| 06/15/2011 | EP2333115A1 Alternative nucleotides for improved targeted nucleotide exchange |
| 06/15/2011 | EP2333109A1 Composition for detection of rna |
| 06/15/2011 | EP2333108A1 Method for detecting the drug effects of dna methylation-inhibitors |
| 06/15/2011 | EP2333099A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333098A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333097A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333096A2 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 06/15/2011 | EP2333095A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
| 06/15/2011 | EP2333091A2 Vectors and methods for genetic immunization |
| 06/15/2011 | EP2333090A1 Procedure for producing transgenic plants providing high starch content and yield and high amylose/amylopectin balance |
| 06/15/2011 | EP2333089A1 Class I homeodomain leucine zipper (HDZip) hox5 polypetide-expressing plants having improved growth characteristics and a method for making the same |
| 06/15/2011 | EP2333088A1 Antifungal polypeptides |
| 06/15/2011 | EP2333087A1 Yield increase in plants overexpressing the SHSRP genes |
| 06/15/2011 | EP2333086A1 Use of a lupinus protein |
| 06/15/2011 | EP2333085A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333084A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333083A1 Production of high mannose human glucocerebrosidease in plant culture |
| 06/15/2011 | EP2333082A1 Cry1F and Cry1AC transgenic cotton lines and event-specific identification thereof |
| 06/15/2011 | EP2333081A2 Tabacco plants having reduced nicotine demethylase activity |
| 06/15/2011 | EP2333080A1 Methods and means for delaying seed shattering in plants |
| 06/15/2011 | EP2333079A1 Chimeric promoters for use in plants |
| 06/15/2011 | EP2333078A2 Proteins associated with abiotic stress response and homologs |
| 06/15/2011 | EP2333077A1 Storage-induced promoter |
| 06/15/2011 | EP2333076A2 Low acrylamide foods |
| 06/15/2011 | EP2333075A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333074A1 Substances and methods for the treatment of lysosmal storage diseases |
| 06/15/2011 | EP2333073A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333072A1 Schizochytrium PKS genes |
| 06/15/2011 | EP2333071A1 Schitzochytrium PKS genes |
| 06/15/2011 | EP2333070A2 Defensin polynucleotides and methods of use |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333068A1 Method for isolation of soluble polypeptides |
| 06/15/2011 | EP2333067A1 Method for isolation of soluble polypeptides |
| 06/15/2011 | EP2333066A1 Method for isolation of soluble polypeptides |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2333063A1 Inducible small interfering RNA (sirna) expression constructs for targeted gene silencing |
| 06/15/2011 | EP2333062A1 RNA-interference by single-stranded RNA molecules |
| 06/15/2011 | EP2333061A1 Delivery of dsRNA to arthropods |
| 06/15/2011 | EP2333060A2 HLA-binding peptides, DNA fragments encoding the same and recombinant vectors |
| 06/15/2011 | EP2333059A1 Universal nucleic acid probe set and method for utilization thereof |
| 06/15/2011 | EP2333058A1 Method for promotion of branch formation, dwarfing, sterility and promotion of multiple flower bud formation of plant |
| 06/15/2011 | EP2333055A1 Subtilase variants |
| 06/15/2011 | EP2333054A2 Novel hydrogenase isolated from thermococcus spp., genes encoding the same, and methods for producing hydrogen using microorganisms with the genes |
| 06/15/2011 | EP2333053A1 Glycerol-3-phosphate phosphatase and glycerol-3-phosphate dehydrogenase from candida albicans, genes encoding the same, vector and host cell containing the genes, and method for producing glycerol using the host cell |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |
| 06/15/2011 | EP2333051A1 Dominant gene suppression transgenes and methods of using same |
| 06/15/2011 | EP2333050A1 B cell-derived ips cells and application thereof |
| 06/15/2011 | EP2333045A2 Gene Inactivated Mutants with Altered Protein Production |
| 06/15/2011 | EP2332993A1 Human monoclonal antibody to the human epidermal growth factor receptor |
| 06/15/2011 | EP2332991A2 Humanized anti-cd4 antibody with immunosuppressive properties |
| 06/15/2011 | EP2332989A1 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 06/15/2011 | EP2332984A2 Tumor angiogenesis associated genes and a method for their identification |
| 06/15/2011 | EP2332982A1 Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332977A2 ActRII receptor polypeptides |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |